Arno Therapeutics, Inc 3
3 · Arno Therapeutics, Inc · Filed Jan 9, 2017
Insider Transaction Report
Form 3
Zucker Jonathan J
10% Owner
Holdings
2013 Series D Warrants
Exercise: $1.75From: 2013-10-29Exp: 2018-10-29→ Common Stock (1,383,702 underlying)2012 Series A Warrants
Exercise: $1.14From: 2013-10-29Exp: 2017-11-26→ Common Stock (1,605,809 underlying)- 4,285,111
Common Stock